High fat (HF) diets are known to induce changes in synaptic plasticity in the forebrain leading to learning and memory impairments. Previous studies of oleanolic acid derivatives have found that these compounds can cross the blood-brain barrier to prevent neuronal cell death. We examined the hypothesis that the oleanolic acid derivative, bardoxolone methyl (BM) would prevent diet-induced cognitive deficits in mice fed a HF diet. C57BL/6J male mice were fed a lab chow (LC) (5% of energy as fat), a HF (40% of energy as fat), or a HF diet supplemented with 10 mg/kg/day BM orally for 21 weeks. Recognition memory was assessed by performing a novel object recognition test on the treated mice. Downstream brain-derived neurotrophic factor (BDNF) signalling molecules were examined in the prefrontal cortex (PFC) and hippocampus of mice via Western blotting and N-methyl-D-aspartate (NMDA) receptor binding. BM treatment prevented HF diet-induced impairment in recognition memory (p b 0.001). In HF diet fed mice, BM administration attenuated alterations in the NMDA receptor binding density in the PFC (p b 0.05), however, no changes were seen in the hippocampus (p N 0.05). In the PFC and hippocampus of the HF diet fed mice, BM administration improved downstream BDNF signalling as indicated by increased protein levels of BDNF, phosphorylated tropomyosin related kinase B (pTrkB) and phosphorylated protein kinase B (pAkt), and increased phosphorylated AMP-activated protein kinase (pAMPK) (p b 0.05). BM administration also prevented the HF diet-induced increase in the protein levels of inflammatory molecules, phosphorylated c-Jun N-terminal kinase (pJNK) in the PFC, and protein tyrosine phosphatase 1B (PTP1B) in both the PFC and hippocampus. In summary, these findings suggest that BM prevents HF diet-induced impairments in recognition memory by improving downstream BDNF signal transduction, increasing pAMPK, and reducing inflammation in the PFC and hippocampus.
Introduction
Obesity is a major risk factor for the development of cognitive decline in neurodegenerative disease such as vascular dementia (Hassing et al., 2002) . A number of studies provide direct evidence demonstrating a link between high fat (HF) diet-induced obesity and impairments in learning and memory performance, including a decline in recognition memory (Greenwood and Winocur, 1990, 1996; Heyward et al., 2012) . Furthermore, preclinical animal studies have demonstrated that a HF diet reduces synaptic plasticity in the prefrontal cortex (PFC) (Val-Laillet et al., 2011) and hippocampus (Molteni et al., 2002; Wu et al., 2003) , which leads to learning and memory impairments (Laroche et al., 2000) . A HF diet can further induce cognitive decline by promoting neuroinflammation in the forebrain (Miller and Spencer, 2014) . Despite this, therapeutic interventions targeting HF diet-induced cognitive impairment are lacking.
The oleanolic acid synthetic derivative, bardoxolone methyl (BM) has attracted attention due to its potential application in a wide variety of diseases (Camer and Huang, 2014; Camer et al., 2014; Liby and Sporn, 2012; Reisman et al., 2012; Wang et al., 2011) . A recent study found that BM can promote dopaminergic neuroprotection via attenuation of the inflammatory mediator, tumour necrosis factor alpha (TNFα), and reactive oxygen species (ROS) production in vitro (Tran et al., 2008) . Despite this finding no study has subsequently investigated the effects of BM on the brain in vivo. However, a derivative of BM, CDDO-MA, improved
